69.1 F
Fort Worth
Thursday, October 22, 2020
Banking Southlake private equity firm makes investment in Plano health economics, research firm

Southlake private equity firm makes investment in Plano health economics, research firm

Other News

A look at big issues on Supreme Court’s agenda

Some of the issues either already on the Supreme Court's docket when it begins its new session or likely to be before...

Wall Street posts solid gains after surge in corporate deals

By ALEX VEIGA and DAMIAN J. TROISE AP Business Writers Wall Street kicked off the week with a broad...

Tarrant County ranks low in work-from-home study by NAR

North Texas ranks pretty high in the “Work from Home” category, according to a just-released study by the National Association of Realtors....

Commentary: Universities and COVID-19: Charting turbulent times

Ray Perryman As the COVID-19 pandemic emerged this spring, college campuses across the United States swiftly sent students...

Southlake-based private equity firm Ancor Capital Partners has acquired STATinMED Research, a leading medical technology company in the health economics and outcomes research – HEOR – industry. The transaction was finalized Sep. 7 and represents Ancor’s largest acquisition to date. Terms of the transaction were not disclosed.

As one of the world’s leading HEOR companies, STATinMED provides health care uses real world data to accelerate research and generate evidence that provides enhanced decision-making capabilities for the market. Using their customized research methodologies and a diverse set of data sources, STATinMED draws on millions of data points to develop strategies that deliver better clinical outcomes, higher cost savings and greater value at every stage of the pharmaceutical product lifecycle. STATinMED collaborates with its clients in the pharmaceutical, biotechnology and health information fields to deliver demonstrable results that allow for greater confidence in marketability, pricing strategies, product development, various treatment mixes, economic vitality and cost-effectiveness that ultimately results in the better overall quality of patient care.

Founded in 2007 by Onur Baser, Ph.D., STATinMED’s interdisciplinary team includes numerous industry specialists that hold advanced degrees or academic positions with prestigious universities and bring expertise in health economics, pharmacoeconomics, clinical or outcomes research, research design, econometrics, statistics and biostatistics. STATinMED has three U.S. locations – Plano; Ann Arbor, Michigan; and New York.

“Adding STATinMED Research to the Ancor portfolio complements our long-term growth strategy – taking established, successful companies and accelerating their position in the market,” said Vic Keller, managing partner at Ancor Capital Partners. “The HEOR industry is a complex and fast-growing discipline. As the nation’s economy continues to be challenged by escalating health care costs, STATinMED has emerged as one of the primary drivers of innovation whose trusted research influences strategic health care decision-making.”

“It is an honor to be part of this extraordinary team of professionals who are doing such important and purposeful work in the health care industry. Dr. Baser and his team have done an outstanding job building, growing and executing the vision of STATinMED. Their passion and leadership have instilled a culture of success that has positioned STATinMED to be the preferred partner for the HEOR needs of major pharmaceutical and health care companies. We are excited for the tremendous market opportunities in front of STATinMED and believe that Ancor’s operational expertise and established resources will help propel STATinMED to the next level.”

“We are excited to partner with Ancor as we execute our next phase of growth,” said Baser, founder and chief scientific officer of STATinMED. “We have an incredibly driven culture and are passionate about providing elite services to our customers. I am confident that Ancor’s strategies will align with our vision, and their extensive experience and resources will position STATinMED to capitalize on the opportunities ahead.”

The transaction was led by Keller. Keller joined Ancor Capital Partners in 2017 and brings over 20 years of experience in establishing, growing and optimizing businesses. Keller will assume the role of chairman at STATinMED effective immediately.

Ancor partnered with Capital Southwest Corporation, CION Investments, Harbert Management Corporation and Dos Rios Partners to finance the acquisition with senior debt and co-invested equity.

This transaction represents the 52nd investment for Ancor Capital Partners.

Latest News

Texas reports most active COVID-19 cases since summer peak

AUSTIN, Texas (AP) — The second coronavirus wave in Texas continued with more active cases than at any time since the summertime...

First Cash Financial Services: 3Q Earnings Snapshot

FORT WORTH, Texas (AP) _ First Cash Financial Services Inc. (FCFS) on Wednesday reported third-quarter profit of $15.1 million.The Fort Worth-based company...

BOK Financial: 3Q Earnings Snapshot

TULSA, Okla. (AP) _ BOK Financial Corp. (BOKF) on Wednesday reported third-quarter profit of $154 million.The Tulsa, Oklahoma-based bank said it had...

Texas Capital: 3Q Earnings Snapshot

DALLAS (AP) _ Texas Capital Bancshares Inc. (TCBI) on Wednesday reported third-quarter earnings of $57.1 million.The bank, based in Dallas, said it...

Tarrant County reports 1 COVID death

Tarrant County Public Health on Wednesday, Oct. 21 reported one COVID-19 death. The deceased was a man from Haltom City in his...